Pacific Biosciences of California, Inc. (PACB) Social Stream
PACIFIC BIOSCIENCES OF CALIFORNIA INC (PACB) Price Targets From Analysts
Use the tables below to see what analysts covering PACIFIC BIOSCIENCES OF CALIFORNIA INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 5 | $62 | $32 | $45.2 | $9.4 | 380.85% |
| 2022-01-06 | 6 | $62 | $20 | $40.333 | $9.4 | 329.07% |
| 2022-01-24 | 6 | $50 | $20 | $36 | $9.4 | 282.98% |
| 2022-01-25 | 6 | $50 | $20 | $35.166 | $9.4 | 274.11% |
| 2022-02-16 | 6 | $50 | $15 | $31.5 | $9.4 | 235.11% |
| 2022-02-17 | 6 | $45 | $15 | $25 | $9.4 | 165.96% |
| 2022-02-28 | 6 | $45 | $13 | $22.6 | $9.4 | 140.43% |
| 2022-04-05 | 6 | $45 | $13 | $23.833 | $9.4 | 153.54% |
| 2022-04-20 | 6 | $45 | $11 | $22.833 | $9.4 | 142.9% |
| 2022-05-06 | 6 | $45 | $11 | $21 | $9.4 | 123.4% |
| 2022-05-09 | 6 | $45 | $11 | $20.333 | $9.4 | 116.31% |
| 2022-05-17 | 6 | $45 | $6 | $19.166 | $9.4 | 103.89% |
| 2022-07-15 | 6 | $45 | $6 | $18.833 | $9.4 | 100.35% |
| 2022-08-04 | 6 | $19 | $6 | $11.333 | $9.4 | 20.56% |
| 2022-08-17 | 6 | $14 | $7.5 | $10.25 | $9.4 | 9.04% |
| 2022-09-01 | 5 | $14 | $6 | $10 | $9.4 | 6.38% |
| 2022-11-13 | 4 | $14 | $6 | $10 | $9.4 | 6.38% |
| 2022-11-16 | 5 | $14 | $6 | $10 | $9.4 | 6.38% |
| 2022-11-17 | 6 | $14 | $10 | $11.833 | $9.4 | 25.88% |
| 2022-12-23 | 6 | $14 | $10 | $12.333 | $9.4 | 31.2% |
| 2023-01-06 | 6 | $14 | $10 | $12.166 | $9.4 | 29.43% |
| 2023-01-27 | 7 | $14 | $10 | $12.142 | $9.4 | 29.17% |
| 2023-02-21 | 8 | $14 | $10 | $12.25 | $9.4 | 30.32% |
| 2023-02-22 | 8 | $14 | $10 | $12.125 | $9.4 | 28.99% |
| 2023-04-04 | 8 | $15 | $10 | $12.375 | $9.4 | 31.65% |
| 2023-04-13 | 8 | $15 | $10 | $12.5 | $9.4 | 32.98% |
| 2023-05-05 | 8 | $17 | $10 | $13.125 | $9.4 | 39.63% |
| 2023-05-07 | 8 | $17 | $12 | $13.5 | $9.4 | 43.62% |
| 2023-05-10 | 9 | $17 | $12 | $13.555 | $9.4 | 44.2% |
| 2023-06-05 | 9 | $17 | $12 | $13.888 | $9.4 | 47.74% |
| 2023-07-05 | 10 | $17 | $12 | $14.2 | $9.4 | 51.06% |
| 2023-08-03 | 10 | $19 | $13 | $14.5 | $9.4 | 54.26% |
| 2023-08-07 | 10 | $19 | $13 | $14.9 | $9.4 | 58.51% |
| 2023-09-28 | 11 | $19 | $11 | $14.545 | $9.4 | 54.73% |
| 2023-09-29 | 11 | $19 | $9 | $14.09 | $9.4 | 49.89% |
| 2023-10-15 | 11 | $19 | $9 | $13.727 | $9.4 | 46.03% |
| 2023-10-31 | 11 | $19 | $9 | $13.454 | $9.4 | 43.13% |
| 2023-11-07 | 11 | $19 | $8 | $12.818 | $9.4 | 36.36% |
| 2023-11-17 | 11 | $19 | $8 | $12.545 | $9.4 | 33.46% |
| 2023-12-15 | 11 | $19 | $8 | $12.727 | $9.4 | 35.39% |
The Trend in the Analyst Price Target
Over the past 47 weeks, PACB's average price target has gone up $0.59.
PACB reports an average of 38.25% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-20 | 7 | 14 | 10 | 12.142 | 11.29 | 7.55% |
| 2023-02-21 | 8 | 14 | 10 | 12.250 | 9.14 | 34.03% |
| 2023-06-30 | 10 | 17 | 12 | 14.200 | 13.30 | 6.77% |
| 2023-08-03 | 10 | 19 | 13 | 14.800 | 11.52 | 28.47% |
| 2023-08-07 | 10 | 19 | 13 | 14.900 | 11.94 | 24.79% |
PACB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.55 | 8 | 0 | 3 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
Over the past 26 weeks, PACB's average broker recommendation rating improved by 0.56.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how PACIFIC BIOSCIENCES OF CALIFORNIA INC fares relative to all US stocks, note that its average analyst price target is higher than 860.6% of that group.
- PACB has a lower variance in analysts' estimates than -2821.19% of all US stocks.
- PACIFIC BIOSCIENCES OF CALIFORNIA INC's upside potential (average analyst target price relative to current price) is greater than 3043.11% of Measuring and Control Equipment stocks.
- In terms of how PACIFIC BIOSCIENCES OF CALIFORNIA INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 2033.68% of that group.
In the Measuring and Control Equipment industry, OLK, CTKB, and BNGO are the three stocks most similar to PACIFIC BIOSCIENCES OF CALIFORNIA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is PACB a Buy, Hold or Sell? See the POWR Ratings now!